Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Toxicity of Subcutaneous Ketamine in the Management of Cancer Pain

Abstract

Ketamine does not have net clinical benefit when used as an adjunct to opioids and standard coanalgesics in cancer pain.